Decreased expression of Wilms' tumor gene WT-1 and elevated expression of insulin growth factor-II (IGF-II) and type 1 IGF receptor genes in prostatic stromal cells from patients with benign prostatic hyperplasia

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 7, 1997, Pages 2198-2203

  Dong, Gangyi ^a   Rajah, Roopmathy ^a   Vu, Thanh ^b   Hoffman, Andrew R ^b   Rosenfeld, Ron G ^c   Roberts Jr , Charles T ^c   Peehl, Donna M ^b   Cohen, Pinchas ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SOMATOMEDIN B; SOMATOMEDIN C RECEPTOR;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; NEPHROBLASTOMA; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RECEPTOR GENE; STROMA CELL; TUMOR SUPPRESSOR GENE;

AGED; AGED, 80 AND OVER; DNA-BINDING PROTEINS; GENE EXPRESSION; GENES, WILMS TUMOR; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; RECEPTOR, IGF TYPE 1; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; WT1 PROTEINS;

EID: 0030839835     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.7.2198     Document Type: Article

References (42)

1. Barry MJ. 1990 Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am. 17:495-499.
2. Carter HB, Coffey DS. 1990 The prostate: an increasing medical problem. Prostate. 16:39-48.
3. Franks LM. 1974 Benign nodular hyperplasia of the prostate. A review. Ann R Coll Surg Engl. 14:92-106.
4. McNeal JE. 1990 Pathology of benign prostatic hyperplasia: Insight into etiology. Urol Clin N Amer. 17:477-486.
5. McNeal JE. 1978 Origin and evolution of benign prostatic enlargement. Invest Urol. 15:340-345.
6. Isaacs JT, Coffey DS. 1989 Etiology and disease process of benign prostatic hyperplasia. Prostate. 2:33-50.
7. Rotwein P. 1991 Structure, evolution, expression and regulation of insulin-like growth factors I and II. Growth Factors. 5:3-18.
8. Nissley P, Lopaczynski W. 1991 Insulin-like growth factor receptors. Growth Factors. 5:29-43.
9. Cohen P, Rosenfeld RG. 1994 Physiological and clinical relevance of the IGFBPs. Curr Opin Pediatr. 6:462-467.
10. Rajah R, Katz L, Nunn S, Solberg P, Beers T, Cohen P. 1996 IGFBP proteases-functional regulators of cell growth. Prog Growth Factors Res. 6:273-284.
11. Cohen P, Rosenfeld RG. 1996 Growth regulation. In: Griffin, Ojeda (eds) Textbook of Endocrine Physiology. Oxford: Oxford University Press; 244-259.
12. LeRoith D, Baserga R, Helman L, Roberts, Jr, CT. 1995 Insulin-like growth factors, and cancer. Ann Int Med. 122:54-59.
13. Pietrzkowski Z, Lammers R, Carpenter G, et al. 1992 Constitute expression of insulin-like growth factor 1 and insulin growth factor 1 receptor abrogates all requirements for exogenous growth factors. Cell Growth & Differ. 3:199-205.
14. Dicicco-Bloom E, Black I. 1988 Insulin-like growth factor regulates the mitotic cycle in cultured rat sympathetic neuroblasts. Proc Natl Acad Sci USA. 85:4066-4072.
15. Rauscher FJ. 1993 The WT-1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J. 7:896-903.
16. Kreidberg JA, Sariola H, Loring JM, et al. 1993 WT-1 is required for early kidney development. Cell. 74:679-691.
17. Haber DA, Park S, Maheswaran S, et al. 1993 WT-1-mediated growth suppression of Wilms tumor cells expressing a WT-1 splicing variant. Science. 262:2057-2059.
18. Yun K, Fidler AE, Eccles MR, Reeve AE. 1993 Insulin-like growth factor II and WT-1 transcript localization in human fetal kidney and Wilms' tumor. Cancer Res. 53:5166-5171.
19. Werner H, Re GG, Drummond IA, et al. 1993 Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT-1 Wilms tumor gene product. Proc Natl Acad Sci USA. 90:5828-5832.
20. Hastie ND. 1993 Wilms' tumor gene and function. Curr Opin Genet Dev. 3:408-413.
21. Werner H, Shen-Orr Z, Rauscher FJ, Morris JF, Roberts CT, LeRoith D. 1995 Inhibition of cellular proliferation by the Wilms' tumor suppressor WT-1 is associated with suppression of insulin-like growth factor I receptor gene expression. Mol Cell Biol. 15:3516-3522.
22. Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG. 1992 Prostrate specific antigen (PSA) is an IGF binding protein-3 (IGFBP-3) protease found in seminal plasma. J Clin Endocrinol Metab. 75:1046-1053.
23. Cohen P, Peehl DM, Stamey TA, Wilson K, Clemmons DR, Rosenfeld RG. 1993 Elevated levels of insulin-like growth factor binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab. 76:830-835.
24. Lee KO, Oh Y, Cohen P, Peehl DM, Rosenfeld RG. 1994 Identification of IGFBP-5 protease activity in human seminal plasma. J Clin Endocrinol Metab. 79:1367-1372.
25. Cohen P, Peehl DM, Lamson G, Rosenfeld RG. 1991 Insulin-like growth factors (IGFs), IGF receptors and IGF binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab. 73:401-407.
26. Cohen P, Peehl DM, Rosenfeld RG. 1994 The IGF axis in the Prostate. Horm Metab Res. 26:81-84.
27. Peehl DM, Cohen P, Rosenfeld RG. 1995 The IGF system in the prostate. World of Urology. 13:306-311.
28. Cohen P, Peele DM, Hintz RL, Rosenfeld RG. 1994 Insulin-like growth factor axis abnormalities in cultures of prostate stromal cells from patients with benign prostatic hypertrophy. J Clin Endocrinol Metab. 79:1410-1415.
29. Cohen P, Peehl DM, Bhala A, Dong G, Hintz RL, Rosenfeld RG. 1994 The IGF axis in prostatic disease. In: RC Baxter, PD Gluckman, RG Rosenfeld (eds) The IGFs and Their Regulatory Proteins. Amsterdam: Elsevier Science BV; 291-299.
30. Peehl DM. 1992 Culture of human prostatic epithelial cells. In: Freshney RI (ed) Culture of Epithelial Cells. New York: Wiley-Liss; 159-180.
31. Kabalin JN, Peehl DM, Stamey TA. 1989 Clonal growth of human prostatic epithelial cells is stimulated by fibroblasts. Prostate. 14:251-263.
32. Giudice LC, Dsupin BA, Jin IH, Vu TH, Hoffman AR. 1993 Differential expression of messenger ribonucleic acids encoding insulin-like growth factors and their receptors in human uterine endometrium and decidua. J Clin Endocrinol Metab. 76:1115-1122.
33. Tetsuro H, Kathleen D, Matthias V, Thomas S, Peter DV. 1993 Quantitative measurement of relative gene expression in human tumors. In: White BA (ed) Methods in Molecular Biology, PCR protocols. Totowa, NJ: Human Press; vol 15:107-112.
34. Lwamura M, Sluss PM, Casamento JB, Cockett AT. 1993 Insulin-like growth factor 1; action and receptor characterization in human prostate cancer cell lines. Prostate. 22:243-252.
35. Dey BR, Sukhatme VP, Roberts AB, Sporn MB, Rauscher FJ, Kim SJ. 1994 Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT-1 gene product. Mol Endocrinol. 8:595-602.
36. Harrington MA, Konicek B, Song A, Xia XL, Fredericks WJ, Rauscher FJ. 1993 Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus. J Biol Chem. 268:21271-21275.
37. Goodyer P, Dehbi M, Torban E, Bruening W, Pelletier J. 1995 Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, WT-1. Oncogene. 10:1125-1129.
38. Taniguchi T, Sullivan MJ, Ogawa O, Reeve AE. 1995 Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. Proc Natl Acad Sci USA. 92:2159-2163.
39. Werner H, Rauscher FJ, Sukhatme VP, Drummond IA, Roberts CT, LeRoith D. 1994 Transcriptional repression of the insulin-like growth factor 1 receptor (IGF-I-R) gene by the tumor suppressor WT-1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. J Biol Chem. 269:12577-12582.
40. Drummond IA, Madden, SL Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher FJ. 1992 Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT-1. Science. 257:674-678.
41. Menssen HD, Renkl HJ, Rodeck U, et al. 1995 Presence of Wilms' tumor gene (WT-1) transcripts and the WT-1 nuclear protein in the majority of human acute leukemias. Leukemia. 9:1060-1067.
42. Bruening W, Gros P, Sato T, et al. 1993 Analysis of the 11p13 Wilms' tumor suppressor gene (WT-1) in ovarian tumors. Cancer Invest. 11:393-399.